<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Clutton G</submitter><funding>Medical Research Council</funding><funding>The British Council</funding><pagination>1030-5</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4514343</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(4)</volume><pubmed_abstract>Viral vector vaccines designed to elicit CD8(+) T cells in non-human primates exert potent control of immunodeficiency virus infections; however, similar approaches have been unsuccessful in humans. Adenoviral vectors elicit potent T cell responses but also induce production of immunosuppressive interleukin-10 (IL-10), which can limit the expansion of T cell responses. We investigated whether inhibiting IL-10 signaling prior to immunization with a candidate adenovirus vectored-HIV-1 vaccine, ChAdV63.HIVconsv, could modulate innate and adaptive immune responses in BALB/c mice. Transient IL-10 receptor blockade led to a modest but significant increase in the total magnitude CD8(+) T cell response to HIVconsv, but did not affect T cell responses to immunodominant epitopes. Anti-IL-10R-treated animals also exhibited greater expression of CD86 on CD11c(+) dendritic cells. Our data support further investigation and optimization of IL-10 blocking strategies to improve the immunogenicity of vaccines based on replication-defective adenoviruses.</pubmed_abstract><journal>Human vaccines &amp; immunotherapeutics</journal><pubmed_title>Transient IL-10 receptor blockade can enhance CD8(+) T cell responses to a simian adenovirus-vectored HIV-1 conserved region immunogen.</pubmed_title><pmcid>PMC4514343</pmcid><funding_grant_id>G1000800d</funding_grant_id><funding_grant_id>MC_U137884179</funding_grant_id><funding_grant_id>G1001757</funding_grant_id><funding_grant_id>172735957</funding_grant_id><pubmed_authors>Reyes-Sandoval A</pubmed_authors><pubmed_authors>Hanke T</pubmed_authors><pubmed_authors>Dorrell L</pubmed_authors><pubmed_authors>Bridgeman A</pubmed_authors><pubmed_authors>Clutton G</pubmed_authors></additional><is_claimable>false</is_claimable><name>Transient IL-10 receptor blockade can enhance CD8(+) T cell responses to a simian adenovirus-vectored HIV-1 conserved region immunogen.</name><description>Viral vector vaccines designed to elicit CD8(+) T cells in non-human primates exert potent control of immunodeficiency virus infections; however, similar approaches have been unsuccessful in humans. Adenoviral vectors elicit potent T cell responses but also induce production of immunosuppressive interleukin-10 (IL-10), which can limit the expansion of T cell responses. We investigated whether inhibiting IL-10 signaling prior to immunization with a candidate adenovirus vectored-HIV-1 vaccine, ChAdV63.HIVconsv, could modulate innate and adaptive immune responses in BALB/c mice. Transient IL-10 receptor blockade led to a modest but significant increase in the total magnitude CD8(+) T cell response to HIVconsv, but did not affect T cell responses to immunodominant epitopes. Anti-IL-10R-treated animals also exhibited greater expression of CD86 on CD11c(+) dendritic cells. Our data support further investigation and optimization of IL-10 blocking strategies to improve the immunogenicity of vaccines based on replication-defective adenoviruses.</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015</publication><modification>2021-02-21T01:16:43Z</modification><creation>2019-03-27T01:55:48Z</creation></dates><accession>S-EPMC4514343</accession><cross_references><pubmed>25751015</pubmed><doi>10.1080/21645515.2015.1009809</doi></cross_references></HashMap>